Sufoxazine
Alternative Names: Lucelan; Metatone; Teniloxazine; Y 8894Latest Information Update: 22 Nov 1999
At a glance
- Originator Mitsubishi Pharma Corporation
- Class Antidepressants; Antiulcers
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 22 Nov 1999 No-Development-Reported for Alzheimer's disease in Japan (PO)
- 22 Nov 1999 No-Development-Reported for Depression in Japan (PO)
- 09 Jan 1997 Phase-III clinical trials for Depression in Japan (PO)